Ultimately, targeting H19 may represent a novel therapeutic approach to promote apoptosis and inhibit tumor growth in thyroid cancer by inhibiting the activation of the PI3K/AKT signaling axis [41]. Here, PIK3CG is linked to thyroid cancer.